Clara Bloomfield, MD, Hematology, Columbus, OH, James Cancer Hospital and Solove Research Institute

ClaraD.BloomfieldMD

Hematology Columbus, OH

Hematologic Oncology

Professor, Internal Medicine, Ohio State University College of Medicine

Dr. Bloomfield is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bloomfield's full profile

Already have an account?

Education & Training

  • University of Minnesota
    University of MinnesotaFELLOWSHIP
  • University of Minnesota
    University of MinnesotaCHIEF_RESIDENCY
  • University of Chicago
    University of ChicagoRESIDENCY
  • University of Chicago
    University of ChicagoINTERNSHIP
  • University of Chicago Pritzker School of Medicine
    University of Chicago Pritzker School of MedicineMEDICAL_SCHOOL
  • San Diego State CollegeOTHER_TRAINING

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1997 - 2021
  • MN State Medical License
    MN State Medical License Active through 2020
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Achievement Richard L. Schilsky Cancer and Leukemia Group B, 2012
  • Member American Academy of Arts & Sciences, 2011
  • David A. Karnofsky Memorial American Society of Clinical Oncology, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Recurring chromosome abnormalities in Hodgkin's disease.  
    Döhner H, Bloomfield CD, Frizzera G, Frestedt J, Arthur DC, Genes Chromosomes Cancer. 1992 Nov;5(4):392-8
  • Ras oncogene activation and occupational exposures in acute myeloid leukemia.  
    Taylor JA, Sandler DP, Bloomfield CD, Shore DL, Ball ED, Neubauer A, McIntyre OR, Liu E, J Natl Cancer Inst 1992 Nov 4;84(21):1626-32.1632
  • Clinical Significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B study.  
    Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davy FR, Wurster-Hill D, Sobol R, Schiffer CA, Bloomfield CD, Blood. 1992 Dec 15;80(12):2983- 90
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • CircPCMTD1: A Protein-Coding Circular RNA That Regulates DNA Synthesis in Leukemic Myeloblasts
    Clara D. Bloomfield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The Influence of the Age of the Bone Marrow Microenvironment on Leukaemia Progression
    Clara D. Bloomfield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • DNA Methylation-Based Classification Highlights the Role of the JAK-STAT Pathway in Acute Myeloid Leukemia
    Clara D. Bloomfield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid L... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete R... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Clinical and Molecular Characteristics of Acute Myeloid Leukemia (AML) Patients with TP53 Mutations and TP73 Mutations 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Other

Press Mentions

  • You Must Remember Meeting Clara: Remembering Clara Derber Bloomfield (1942–2020)
    You Must Remember Meeting Clara: Remembering Clara Derber Bloomfield (1942–2020)May 04, 2020
  • Oncology Community Mourns the Death of Clara D. Bloomfield
    Oncology Community Mourns the Death of Clara D. BloomfieldMarch 04, 2020
  • ASCO President, Bruce E. Johnson, MD, FASCO, Participates in Key Research with EGFR Mutation in Lung Cancer
    ASCO President, Bruce E. Johnson, MD, FASCO, Participates in Key Research with EGFR Mutation in Lung CancerJune 03, 2017
  • Join now to see all

Grant Support

  • Cancer And Leukemia Group B - The Ohio State UniversityNational Cancer Institute2003–2012
  • Molecular Characterization And Risk Stratification Of Acute Myeloid LeukemiaNational Cancer Institute2009–2011
  • Developmental Research ProgramNational Cancer Institute2009–2011
  • Career Development ProgramNational Cancer Institute2009–2011
  • CalgbNational Cancer Institute1999–2002
  • Comprehensive Cancer CenterNational Cancer Institute1995–2002
  • Cancer And Leukemia Group B--Correlative SciencesNational Cancer Institute1997
  • Cancer And Leukemia Group B--Correlative SciencesNational Cancer Institute1993–1996
  • Osu Comprehensive Cancer Support Core Grant SupplementNational Cancer Institute1994
  • Cancer CenterNational Cancer Institute1994
  • Osu Comprehensive Cancer Center Support (CORE) GrantNational Cancer Institute1991–1993
  • Cancer And Leukemia Group B Immunology And GeneticsNational Cancer Institute1989–1992
  • Comprehensive Cancer Center Support GrantNational Cancer Institute1988–1990
  • Clinical/Lab Studies--Lymphoproliferative DiseasesNational Cancer Institute1989
  • Cancer And Leukemia Group B Immunology And GeneticsNational Cancer Institute1988–1989
  • Cancer And Leukemia Group B Immunology And CytogeneticsNational Cancer Institute1985–1987
  • Glucocorticoid Receptors In Human Leukemia And LymphomaNational Cancer Institute1985

Professional Memberships

Hospital Affiliations